AR034553A1 - Triazolopirimidinas sustituidas, medicamento que los contienen, composiciones farmaceuticas y el uso de dichos derivados para la fabricacion de medicamentos como agentes anticancerosos - Google Patents
Triazolopirimidinas sustituidas, medicamento que los contienen, composiciones farmaceuticas y el uso de dichos derivados para la fabricacion de medicamentos como agentes anticancerososInfo
- Publication number
- AR034553A1 AR034553A1 ARP010103116A ARP010103116A AR034553A1 AR 034553 A1 AR034553 A1 AR 034553A1 AR P010103116 A ARP010103116 A AR P010103116A AR P010103116 A ARP010103116 A AR P010103116A AR 034553 A1 AR034553 A1 AR 034553A1
- Authority
- AR
- Argentina
- Prior art keywords
- optionally substituted
- aryl
- atoms
- cycloalkyl
- alkyl
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 5
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000003795 chemical substances by application Substances 0.000 title 1
- -1 amino, hydroxyl Chemical group 0.000 abstract 13
- 125000000623 heterocyclic group Chemical group 0.000 abstract 13
- 239000001257 hydrogen Substances 0.000 abstract 12
- 229910052739 hydrogen Inorganic materials 0.000 abstract 12
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 12
- 125000004432 carbon atom Chemical group C* 0.000 abstract 11
- 125000004400 (C1-C12) alkyl group Chemical group 0.000 abstract 9
- 125000003118 aryl group Chemical group 0.000 abstract 8
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 8
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 8
- 229910052801 chlorine Inorganic materials 0.000 abstract 7
- 239000000460 chlorine Substances 0.000 abstract 7
- 125000003342 alkenyl group Chemical group 0.000 abstract 6
- 125000000304 alkynyl group Chemical group 0.000 abstract 6
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 abstract 5
- 125000000392 cycloalkenyl group Chemical group 0.000 abstract 5
- YWBFPKPWMSWWEA-UHFFFAOYSA-O triazolopyrimidine Chemical class BrC1=CC=CC(C=2N=C3N=CN[N+]3=C(NCC=3C=CN=CC=3)C=2)=C1 YWBFPKPWMSWWEA-UHFFFAOYSA-O 0.000 abstract 5
- 125000004642 (C1-C12) alkoxy group Chemical group 0.000 abstract 4
- 241000124008 Mammalia Species 0.000 abstract 4
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 4
- 150000001602 bicycloalkyls Chemical group 0.000 abstract 4
- 229910052736 halogen Inorganic materials 0.000 abstract 4
- 150000003839 salts Chemical class 0.000 abstract 4
- 125000006376 (C3-C10) cycloalkyl group Chemical group 0.000 abstract 3
- 125000005809 3,4,5-trimethoxyphenyl group Chemical group [H]C1=C(OC([H])([H])[H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 abstract 3
- 125000004199 4-trifluoromethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C(F)(F)F 0.000 abstract 3
- 125000004414 alkyl thio group Chemical group 0.000 abstract 3
- 125000004429 atom Chemical group 0.000 abstract 3
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 3
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 abstract 3
- 201000010099 disease Diseases 0.000 abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
- 125000001188 haloalkyl group Chemical group 0.000 abstract 3
- 150000002367 halogens Chemical class 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 3
- 210000004881 tumor cell Anatomy 0.000 abstract 3
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 abstract 2
- 125000003282 alkyl amino group Chemical group 0.000 abstract 2
- 125000004104 aryloxy group Chemical group 0.000 abstract 2
- 125000004663 dialkyl amino group Chemical group 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 230000005764 inhibitory process Effects 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 2
- 229920006395 saturated elastomer Polymers 0.000 abstract 2
- 125000004643 (C1-C12) haloalkoxy group Chemical group 0.000 abstract 1
- 125000006713 (C5-C10) cycloalkyl group Chemical group 0.000 abstract 1
- 125000004204 2-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C([H])=C1[H] 0.000 abstract 1
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 abstract 1
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 abstract 1
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 abstract 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 abstract 1
- NSPMIYGKQJPBQR-UHFFFAOYSA-N 4H-1,2,4-triazole Chemical compound C=1N=CNN=1 NSPMIYGKQJPBQR-UHFFFAOYSA-N 0.000 abstract 1
- 102000029749 Microtubule Human genes 0.000 abstract 1
- 108091022875 Microtubule Proteins 0.000 abstract 1
- 229910003827 NRaRb Inorganic materials 0.000 abstract 1
- 102000004243 Tubulin Human genes 0.000 abstract 1
- 108090000704 Tubulin Proteins 0.000 abstract 1
- 125000002102 aryl alkyloxo group Chemical group 0.000 abstract 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 abstract 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 125000001246 bromo group Chemical group Br* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 abstract 1
- 125000006312 cyclopentyl amino group Chemical group [H]N(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000003993 interaction Effects 0.000 abstract 1
- 210000004688 microtubule Anatomy 0.000 abstract 1
- 230000029115 microtubule polymerization Effects 0.000 abstract 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 229940127557 pharmaceutical product Drugs 0.000 abstract 1
- 125000003107 substituted aryl group Chemical group 0.000 abstract 1
- 229930192474 thiophene Natural products 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21558500P | 2000-06-30 | 2000-06-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR034553A1 true AR034553A1 (es) | 2004-03-03 |
Family
ID=22803554
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP010103116A AR034553A1 (es) | 2000-06-30 | 2001-06-29 | Triazolopirimidinas sustituidas, medicamento que los contienen, composiciones farmaceuticas y el uso de dichos derivados para la fabricacion de medicamentos como agentes anticancerosos |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US7329663B2 (en:Method) |
| EP (1) | EP1307200A2 (en:Method) |
| JP (1) | JP2004502691A (en:Method) |
| KR (1) | KR20030013475A (en:Method) |
| CN (1) | CN1592624A (en:Method) |
| AR (1) | AR034553A1 (en:Method) |
| AU (2) | AU2001273062B2 (en:Method) |
| BG (1) | BG107277A (en:Method) |
| BR (1) | BR0112038A (en:Method) |
| CA (1) | CA2413802A1 (en:Method) |
| CZ (1) | CZ20024150A3 (en:Method) |
| EA (1) | EA006483B1 (en:Method) |
| GE (1) | GEP20053688B (en:Method) |
| HK (1) | HK1052646A1 (en:Method) |
| HU (1) | HUP0300798A3 (en:Method) |
| IL (1) | IL152869A0 (en:Method) |
| IN (1) | IN2003KO00001A (en:Method) |
| MX (1) | MXPA02011913A (en:Method) |
| NO (1) | NO20026195L (en:Method) |
| NZ (1) | NZ523807A (en:Method) |
| PL (1) | PL360027A1 (en:Method) |
| SK (1) | SK18412002A3 (en:Method) |
| WO (1) | WO2002002563A2 (en:Method) |
| ZA (1) | ZA200300793B (en:Method) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6255309B1 (en) | 1999-03-19 | 2001-07-03 | American Cyanomid Co. | Fungicidal trifluoromethylalkylamino-triazolopyrimidines |
| AU2002221831A1 (en) * | 2000-11-13 | 2002-05-21 | Basf Aktiengesellschaft | 7-(r)-amino-triazolopyrimidines, the production thereof and use of the same for combating phytopathogenic fungi |
| DE60201089T2 (de) * | 2001-04-11 | 2004-12-30 | Basf Ag | 6-(2-chlor-6-fluor-phenyl)-triazolpyrimidine |
| BR0208756A (pt) * | 2001-04-11 | 2004-05-11 | Basf Ag | Compostos, processo para a preparação dos mesmos, composição adequada para o controle de fungos fitopatogênicos, e, método para controlar fungos fitopatogênicos |
| DE10121101A1 (de) * | 2001-04-27 | 2002-10-31 | Bayer Ag | Triazolopyrimidine |
| DE10121162A1 (de) * | 2001-04-30 | 2002-10-31 | Bayer Ag | Triazolopyrimidine |
| DE10124208A1 (de) | 2001-05-18 | 2002-11-21 | Bayer Ag | Verwendung von Triazolopyrimidin-Derivaten als Mikrobizide |
| IL159606A0 (en) * | 2001-07-18 | 2004-06-01 | Basf Ag | Substituted 6-(2-tolyl)-triazolopyrimidines as fungicides |
| ATE384064T1 (de) * | 2002-03-21 | 2008-02-15 | Basf Ag | Fungizide triazolopyrimidine, verfahren zu ihrer herstellung und ihre verwendung zur bekämpfung von schadpilzen sowie sie enthaltende mittel |
| WO2004011467A1 (ja) * | 2002-07-29 | 2004-02-05 | Hokko Chemical Industry Co., Ltd. | トリアゾロピリミジン誘導体および農園芸用殺菌剤 |
| UA80304C2 (en) * | 2002-11-07 | 2007-09-10 | Basf Ag | Substituted 6-(2-halogenphenyl)triazolopyrimidines |
| US20060211573A1 (en) * | 2003-03-31 | 2006-09-21 | Blasco Jordi T | 7-(Akenylamino)triazolopyrimidines, method for the production thereof and use thereof in controlling harmful fungi and substances containing said triazolopyrimidines |
| EP1644003A1 (en) * | 2003-06-04 | 2006-04-12 | Vernalis (Cambridge) Limited | Triazolo ´1,5-a!pyrimidines and their use in medicine |
| DE10325133A1 (de) * | 2003-06-04 | 2004-12-23 | Bayer Cropscience Ag | Triazolopyrimidine |
| DE10328173A1 (de) * | 2003-06-24 | 2005-01-13 | Bayer Cropscience Ag | Triazolopyrimidine |
| DE10328171A1 (de) * | 2003-06-24 | 2005-01-13 | Bayer Cropscience Ag | Triazolopyrimidine |
| DE10328481A1 (de) * | 2003-06-25 | 2005-01-13 | Bayer Ag | Triazolopyrimidine |
| US7419982B2 (en) | 2003-09-24 | 2008-09-02 | Wyeth Holdings Corporation | Crystalline forms of 5-chloro-6-{2,6-difluoro-4-[3-(methylamino)propoxy]phenyl}-N-[(1S)-2,2,2-trifluoro-1-methylethyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine salts |
| SI1680425T1 (sl) | 2003-09-24 | 2007-04-30 | Wyeth Corp | 6-((substituirani)fenil)triazolopirimidini kot sredstva proti raku |
| DK1684763T3 (da) | 2003-09-24 | 2008-09-01 | Wyeth Corp | 6-Aryl-7-halogen-imidazo(1,2-a)pyrimidiner som anticancermiddel |
| US20070129383A1 (en) * | 2003-10-17 | 2007-06-07 | Hiroshi Kuramochi | Substituted 2-amino-[1,2,4]triazolo[1,5-a]pyrimidine derivative and use thereof |
| JP4606015B2 (ja) * | 2003-11-25 | 2011-01-05 | 日本化薬株式会社 | ［１，２，４］トリアゾロ［１，５−ａ］ピリミジン誘導体の新規医薬用途 |
| MY179926A (en) | 2003-12-08 | 2020-11-19 | Wyeth Corp | Process for the preparation of tubulin inhibitors |
| CN1894254A (zh) * | 2003-12-17 | 2007-01-10 | 巴斯福股份公司 | 用于防治病原性真菌的6－(2,3,6－三氟苯基)三唑并嘧啶 |
| CN1890243A (zh) * | 2003-12-17 | 2007-01-03 | 巴斯福股份公司 | 6－(2,4,6－三卤代苯基)三唑并嘧啶、其制备方法及其在防治病原性真菌中的用途以及包含所述物质的组合物 |
| BRPI0508717A (pt) * | 2004-03-30 | 2007-08-07 | Basf Ag | compostos, processo para preparar os mesmos, agente, semente, e, processo para combater fungos nocivos fitopatogênicos |
| EP1751162A1 (de) * | 2004-05-17 | 2007-02-14 | Basf Aktiengesellschaft | Triazolopyrimidin-verbindungen und ihre verwendung zur bekämpfung von schadpilzen |
| WO2005120233A1 (de) * | 2004-06-09 | 2005-12-22 | Basf Aktiengesellschaft | Triazolopyrimidin-verbindungen und ihre verwendung zur bekämpfung von schadpilzen |
| MXPA06013943A (es) * | 2004-06-25 | 2007-03-15 | Basf Ag | Compuestos de triazolopirimidina y su uso en el control de hongos daninos. |
| US20070155738A1 (en) * | 2005-05-20 | 2007-07-05 | Alantos Pharmaceuticals, Inc. | Heterobicyclic metalloprotease inhibitors |
| EA013525B1 (ru) * | 2005-05-20 | 2010-06-30 | Алантос-Фармасьютикалз Холдинг, Инк. | Гетеробициклические ингибиторы металлопротеазы и их применение |
| WO2007011759A2 (en) * | 2005-07-15 | 2007-01-25 | Kalypsys, Inc. | Inhibitors of mitotic kinesin |
| BRPI0619918A2 (pt) * | 2005-12-16 | 2011-10-25 | Wyeth Corp | dìmeros e adutos de 6-triazolpirimidinas [fenil (substituìdas)] úteis como agentes anticáncer |
| AR059649A1 (es) * | 2006-02-28 | 2008-04-16 | Basf Ag | 6- fenil 7-amino - amino (1,2,4) -triazolo (1,5-a) pirimidinas y su su uso para el combate de hongos daninos |
| WO2007116011A2 (de) * | 2006-04-10 | 2007-10-18 | Basf Se | Substituierte triazolopyrimidine, verfahren zu ihrer herstellung und ihre verwendung zur bekämpfung von schadpilzen sowie sie enthaltende mittel |
| JP5231829B2 (ja) * | 2007-02-15 | 2013-07-10 | 石原産業株式会社 | ピリジル−トリアゾロピリミジン誘導体又はその塩、それらを含有する有害生物防除剤並びにそれらの製造方法 |
| PL2188291T3 (pl) | 2007-08-14 | 2013-06-28 | Bayer Ip Gmbh | Skondensowane bicykliczne pirymidyny |
| CN103889428A (zh) * | 2010-10-04 | 2014-06-25 | 肝炎与病毒研究所 | 乙型肝炎病毒抗原分泌的新型抑制剂 |
| BR112014030147B1 (pt) | 2012-06-22 | 2019-10-15 | Sumitomo Chemical Company, Limited | Compostos heterocíclicos fundidos, composição e método para controlar pestes |
| CN103360398B (zh) * | 2013-07-22 | 2015-03-25 | 山东大学 | 一种三唑并嘧啶类hiv-1逆转录酶抑制剂及其制备方法与应用 |
| GB201504565D0 (en) | 2015-03-18 | 2015-05-06 | Takeda Pharmaceutical | Novel compounds |
| KR101995533B1 (ko) * | 2017-03-21 | 2019-07-02 | 한국화학연구원 | [1,2,4]트리아졸로[4,3-a]퀴노잘린 아미노 페닐 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 포함하는 BET 단백질 관련 질환의 예방 또는 치료용 약학적 조성물 |
| WO2022011171A1 (en) * | 2020-07-08 | 2022-01-13 | Klotho Therapeutics, Inc. | Novel compounds and methods for increasing klotho gene expression |
| WO2020159942A1 (en) * | 2019-01-29 | 2020-08-06 | Tosk, Inc. | Pyrazolopyrimidine modulators of ras gtpase |
| CA3178865A1 (en) * | 2020-04-14 | 2021-10-21 | The Trustees Of The University Of Pennsylvania | Substituted {1,2,4,} triazolo{1,5-a} pyrimidine compounds and use in stabilizing microtubules |
| PE20231304A1 (es) | 2020-05-01 | 2023-08-24 | Gilead Sciences Inc | Compuestos de 2,4-dioxopirimidina inhibidores de cd73 |
| US12180220B2 (en) | 2020-10-14 | 2024-12-31 | Tosk, Inc. | Heteroaryl modulators of RAS GTPase |
| CN118201941A (zh) | 2021-10-29 | 2024-06-14 | 吉利德科学公司 | Cd73化合物 |
| WO2023143194A1 (zh) * | 2022-01-25 | 2023-08-03 | 瑞石生物医药有限公司 | 一种ccr4小分子拮抗剂及其用途 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DD55956A (en:Method) * | ||||
| DE55956C (de) | CH. GROOMBRIDGE und W. A. SOUTH in London, 40 New Bond Street | Bremskurbel für Pferdebahn- und andere Wagen | ||
| DE61269C (de) | 1891-04-01 | 1892-03-23 | J. NEWBURG in Berlin O., Am Schlesischen Bahnhof Nr. 5 | Waschmaschine |
| JPS5827773B2 (ja) * | 1980-02-08 | 1983-06-11 | 持田製薬株式会社 | 癌転移抑制剤 |
| US4444774A (en) * | 1982-07-29 | 1984-04-24 | American Cyanamid Company | 7-Heteroaryl[1,2,4]triazolo[1,5-a]pyrimidines |
| GB8719368D0 (en) * | 1987-08-15 | 1987-09-23 | Wellcome Found | Heterocyclic compounds |
| JPH02212488A (ja) * | 1989-02-13 | 1990-08-23 | Shinichiro Shimizu | トリアゾールピリミジン誘導体 |
| US5593996A (en) * | 1991-12-30 | 1997-01-14 | American Cyanamid Company | Triazolopyrimidine derivatives |
| US5387747A (en) * | 1992-02-24 | 1995-02-07 | Laboratoires Upsa | Triazolopyrimidine derivatives which are angiotensin II receptor antagonists, their methods of preparation and pharmaceutical compositions in which they are present |
| IL108747A (en) * | 1993-03-04 | 1999-03-12 | Shell Int Research | Mushroom-killing preparations containing a history of 6 metamorphoses of 5 - 7 Dihalo - 1, 2 - 4 Triazlo [A-1,5] Pyrimidine Certain such new compounds and their preparation |
| GB9321162D0 (en) * | 1993-10-13 | 1993-12-01 | Boots Co Plc | Therapeutic agents |
| US5869486A (en) * | 1995-02-24 | 1999-02-09 | Ono Pharmaceutical Co., Ltd. | Fused pyrimidines and pyriazines as pharmaceutical compounds |
| US5948783A (en) * | 1997-04-14 | 1999-09-07 | American Cyanamid Company | Fungicidal trifluoromethylalkylamino-triazolopyrimidines |
| US6255309B1 (en) * | 1999-03-19 | 2001-07-03 | American Cyanomid Co. | Fungicidal trifluoromethylalkylamino-triazolopyrimidines |
| US6117876A (en) * | 1997-04-14 | 2000-09-12 | American Cyanamid Company | Fungicidal trifluorophenyl-triazolopyrimidines |
| US5994360A (en) * | 1997-07-14 | 1999-11-30 | American Cyanamid Company | Fungicidal 5-alkyl-triazolopyrimidines |
| US6020338A (en) * | 1998-02-11 | 2000-02-01 | American Cyanamid Company | Fungicidal 7-alkyl-triazolopyrimidines |
| US6380202B1 (en) * | 1998-09-25 | 2002-04-30 | Basf Aktiengesellschaft | Fungicidal fluoro-substituted 7-heterocyclyl-triazolopyrimidines |
| US6165940A (en) * | 1998-09-25 | 2000-12-26 | American Cyanamid Co. | Non-aqueous suspension concentrate |
| FR2784380B1 (fr) * | 1998-09-25 | 2002-09-06 | American Cyanamid Co | Triazolopyrimidines 7-oxy- et 7-thio-substituees fongicides |
| MY125533A (en) * | 1999-12-06 | 2006-08-30 | Bristol Myers Squibb Co | Heterocyclic dihydropyrimidine compounds |
| JP2001322933A (ja) * | 2000-05-15 | 2001-11-20 | Ucb Sa | Ｃｄ４０シグナル遮断剤 |
| DE10121102A1 (de) * | 2001-04-27 | 2002-11-07 | Bayer Ag | Triazolopyrimidine |
| DE10121101A1 (de) * | 2001-04-27 | 2002-10-31 | Bayer Ag | Triazolopyrimidine |
| DE10121162A1 (de) * | 2001-04-30 | 2002-10-31 | Bayer Ag | Triazolopyrimidine |
| US7037902B2 (en) * | 2002-07-03 | 2006-05-02 | Receptron, Inc. | Affinity small molecules for the EPO receptor |
| US7419982B2 (en) * | 2003-09-24 | 2008-09-02 | Wyeth Holdings Corporation | Crystalline forms of 5-chloro-6-{2,6-difluoro-4-[3-(methylamino)propoxy]phenyl}-N-[(1S)-2,2,2-trifluoro-1-methylethyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine salts |
| SI1680425T1 (sl) * | 2003-09-24 | 2007-04-30 | Wyeth Corp | 6-((substituirani)fenil)triazolopirimidini kot sredstva proti raku |
-
2001
- 2001-06-28 NZ NZ523807A patent/NZ523807A/en unknown
- 2001-06-28 CZ CZ20024150A patent/CZ20024150A3/cs unknown
- 2001-06-28 HK HK03104812.5A patent/HK1052646A1/zh unknown
- 2001-06-28 HU HU0300798A patent/HUP0300798A3/hu unknown
- 2001-06-28 PL PL36002701A patent/PL360027A1/xx not_active Application Discontinuation
- 2001-06-28 SK SK1841-2002A patent/SK18412002A3/sk not_active Application Discontinuation
- 2001-06-28 CA CA002413802A patent/CA2413802A1/en not_active Abandoned
- 2001-06-28 JP JP2002507815A patent/JP2004502691A/ja active Pending
- 2001-06-28 MX MXPA02011913A patent/MXPA02011913A/es not_active Application Discontinuation
- 2001-06-28 AU AU2001273062A patent/AU2001273062B2/en not_active Ceased
- 2001-06-28 IL IL15286901A patent/IL152869A0/xx unknown
- 2001-06-28 GE GE5104A patent/GEP20053688B/en unknown
- 2001-06-28 AU AU7306201A patent/AU7306201A/xx active Pending
- 2001-06-28 WO PCT/US2001/020672 patent/WO2002002563A2/en not_active Ceased
- 2001-06-28 BR BR0112038-7A patent/BR0112038A/pt not_active IP Right Cessation
- 2001-06-28 EP EP01952295A patent/EP1307200A2/en not_active Withdrawn
- 2001-06-28 KR KR1020027017998A patent/KR20030013475A/ko not_active Ceased
- 2001-06-28 EA EA200300091A patent/EA006483B1/ru not_active IP Right Cessation
- 2001-06-28 CN CNA018120555A patent/CN1592624A/zh active Pending
- 2001-06-29 US US09/895,975 patent/US7329663B2/en not_active Expired - Fee Related
- 2001-06-29 AR ARP010103116A patent/AR034553A1/es not_active Application Discontinuation
-
2002
- 2002-11-15 BG BG107277A patent/BG107277A/bg unknown
- 2002-12-23 NO NO20026195A patent/NO20026195L/no not_active Application Discontinuation
-
2003
- 2003-01-01 IN IN1KO2003 patent/IN2003KO00001A/en unknown
- 2003-01-29 ZA ZA200300793A patent/ZA200300793B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA006483B1 (ru) | 2005-12-29 |
| US7329663B2 (en) | 2008-02-12 |
| EP1307200A2 (en) | 2003-05-07 |
| IL152869A0 (en) | 2003-06-24 |
| IN2003KO00001A (en:Method) | 2005-12-02 |
| US20020068744A1 (en) | 2002-06-06 |
| HUP0300798A2 (hu) | 2003-07-28 |
| MXPA02011913A (es) | 2003-04-22 |
| AU7306201A (en) | 2002-01-14 |
| KR20030013475A (ko) | 2003-02-14 |
| WO2002002563A2 (en) | 2002-01-10 |
| NO20026195D0 (no) | 2002-12-23 |
| SK18412002A3 (sk) | 2003-06-03 |
| NO20026195L (no) | 2003-02-27 |
| CZ20024150A3 (cs) | 2003-09-17 |
| JP2004502691A (ja) | 2004-01-29 |
| AU2001273062B2 (en) | 2005-11-24 |
| CA2413802A1 (en) | 2002-01-10 |
| CN1592624A (zh) | 2005-03-09 |
| WO2002002563A3 (en) | 2003-01-03 |
| HUP0300798A3 (en) | 2006-02-28 |
| GEP20053688B (en) | 2005-12-12 |
| BG107277A (bg) | 2004-01-30 |
| NZ523807A (en) | 2004-09-24 |
| ZA200300793B (en) | 2004-07-20 |
| HK1052646A1 (zh) | 2003-09-26 |
| BR0112038A (pt) | 2003-04-01 |
| PL360027A1 (en) | 2004-09-06 |
| EA200300091A1 (ru) | 2003-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR034553A1 (es) | Triazolopirimidinas sustituidas, medicamento que los contienen, composiciones farmaceuticas y el uso de dichos derivados para la fabricacion de medicamentos como agentes anticancerosos | |
| PA8547901A1 (es) | Derivados de 4-piperacinilindol con afinidad receptora de 5-ht6 | |
| PA8593001A1 (es) | Derivados de pirimidina para el tratamiento del crecimiento celular anormal | |
| PA8442001A1 (es) | Derivados de pirimidina biciclica condensada | |
| AR040595A1 (es) | Derivados de amina sustituida y metodos de uso | |
| ECSP034444A (es) | Derivados de 4-amino-6-fenil-pirrolo(2,3-d)pirimidina | |
| CR6726A (es) | Compuestos azapoliciclicos condensados con arilo | |
| PA8531001A1 (es) | Compuestos de imidazol condensado con arilo o heteroarilo como agentes anti-inflamatorios y analgesicos | |
| PA8583401A1 (es) | Nuevos compuestos de triazol como inhibidores del factor de crecimiento transformante (tgf) | |
| AR034858A1 (es) | Compuestos elevadores de abca-1,composicion farmaceutica y el uso de los mismos para la manufactura de un medicamento | |
| AR020727A1 (es) | Uso de compuestos derivados 3-amino-4-aril-maleimidas para la preparacion de medicamentos para condiciones asociadas a una necesidad de inhibicion de lagsk-3, dichos compuestos, procedimiento para su preparacion y composiciones farmaceuticas que los comprenden | |
| UY26086A1 (es) | Procedimientos e intermedios para preparar compuestos anticancerosos | |
| PA8575401A1 (es) | Derivados de heteroarilamida benzocondensada de tienopiridinas utiles como agentes terapeuticos, composiciones farmaceuticas que incluyen a los mismos y metrodos para su uso | |
| PA8432301A1 (es) | Analogos de indazol sustituido. | |
| UY26713A1 (es) | Derivados pirazol tricíclicos | |
| AR039985A1 (es) | Compuesto de pirimidinona, composicion farmaceutica que lo comprende y su uso para la elaboracion de esta ultima | |
| AR023574A1 (es) | Compuestos de azepinindol tetraciclico,composiciones farmaceuticas y el uso de dichos compuestos para preparar un medicamento, e intermediarios | |
| AR028810A1 (es) | Derivados de arilpiperazinil-ciclohexil indol, composiciones farmaceuticas que los comprenden y el uso de los mismos para la manufactura de medicamentos para el tratamiento de la depresion | |
| AR041997A1 (es) | Derivados de oxaxol sustituidos, composiciones farmaceuticas que los contienen y su uso en la fabricacion de medicamentos para el tratamiento de la diabetes | |
| AR042941A1 (es) | Derivados de tiazol, su preparacion, composiciones farmaceuticas que los contienen y su uso en la fabricacion de medicamentos inhibidores de la proteina-1 de adhesion vascular (vap-1) | |
| DOP2004000949A (es) | Derivados de pirrolo [3,4-c]pirazol activos como inhibidores de cinasa, proceso para su preparacion y composiciones farmaceuticas que comprenden los mismos | |
| AR028624A1 (es) | Heterociclilalquilaminas como antagonistas de receptores muscarinicos | |
| ECSP034796A (es) | DERIVADOS DIHIDRO-BENZO[b][1,4]DIAZEPIN-2-ONA ANTAGONISTAS I MGLUR2 | |
| ECSP034602A (es) | Derivados sustituidos 2-fenilaminoimidazolina fenil cetona como antagonistas ip | |
| UY27786A1 (es) | Derivados de isoquinolina. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |